Medicus Pharma (NASDAQ:MDCX), a biotech company focused on novel therapeutics, will participate in the 38th Annual Roth Conference in Dana Point, California, running from 22 to 24 March.
Chief executive Raza Bokhari will take part in a fireside chat hosted by Roth Capital Partners, covering the company's clinical programmes, including Skinject's potential in Gorlin Syndrome, a rare genetic condition, as well as its artificial intelligence-driven drug development strategy. One-on-one meetings with institutional investors will also be available throughout the event.